Literature DB >> 14575150

Identification of genes expressed in tumor-associated macrophages.

Eva Gottfried1, Stefan Faust, Jana Fritsche, Leoni A Kunz-Schughart, Reinhard Andreesen, Kensuke Miyake, Marina Kreutz.   

Abstract

Most malignant tumors contain so-called tumor-associated macrophages (TAM) as a major component of their leukocytic infiltrate. To investigate the impact of the tumor microenvironment on activation and differentiation of macrophages, we established a 3-dimensional model system by culturing human monocytes within multicellular tumor spheroids. After 7 days, monocyte-derived TAM were isolated and analyzed for phenotypic alterations as compared to macrophages cultured without tumor cell contact. We found the known macrophage differentiation marker Carboxypeptidase M to be suppressed while CD14, HLA-DR, and CD16 were up-regulated. Using Differential Display, we identified several genes that were differentially expressed between TAM and control macrophages. Prolidase, a peptidase known to influence the chemoattraction of neutrophils and macrophage activity, was down-regulated in TAM. In contrast, the Toll-like receptor family-related molecules MD-1 and RP105 were up-regulated by tumor cell contact, both at the RNA and protein level. From our data we conclude that TAM represent a distict macrophage population characterized by low expression of differentiation-associated macrophage antigens but also by a constitutive state of activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575150     DOI: 10.1078/0171-2985-00246

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.

Authors:  Zhanlong Shen; Tuuli Kauttu; Hanna Seppänen; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  Med Oncol       Date:  2012-03-22       Impact factor: 3.064

2.  Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.

Authors:  Peter H O'Donnell; Eric Gamazon; Wei Zhang; Amy L Stark; Emily O Kistner-Griffin; R Stephanie Huang; M Eileen Dolan
Journal:  Pharmacogenet Genomics       Date:  2010-05       Impact factor: 2.089

3.  Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics.

Authors:  Antje Blumenthal; Jörg Lauber; Reinhard Hoffmann; Martin Ernst; Christine Keller; Jan Buer; Stefan Ehlers; Norbert Reiling
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.

Authors:  Ulrich Joimel; Caroline Gest; Jeannette Soria; Linda-Louise Pritchard; Jérôme Alexandre; Marc Laurent; Emmanuel Blot; Lionel Cazin; Jean-Pierre Vannier; Rémi Varin; Hong Li; Claudine Soria
Journal:  BMC Cancer       Date:  2010-07-17       Impact factor: 4.430

5.  Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression.

Authors:  Pampee P Young; Shidrokh Ardestani; Bin Li
Journal:  Cancer Microenviron       Date:  2010-04-20

Review 6.  Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.

Authors:  Gianluca Colella; Flavio Fazioli; Michele Gallo; Annarosaria De Chiara; Gaetano Apice; Carlo Ruosi; Amelia Cimmino; Filomena de Nigris
Journal:  Int J Mol Sci       Date:  2018-02-21       Impact factor: 5.923

7.  Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Chen Liu; Xuhui Zhang; Caoyang Hu; Xuezhi Liang; Xiaoming Cao; Dongwen Wang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.